(2S,3R,4R,E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid

Catalog No. :
ACTJKO184
CAS No. :
35891-70-4
Molecular Formula :
C21H39NO6
Molecular Weight :
401.54

IUPAC Name:(2S,3R,4R,E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid

(2S,3R,4R,E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$124.00Login to see priceInquiryInquiry
5mg98%$327.00Login to see priceInquiryInquiry
10mg98%$545.00Login to see priceInquiryInquiry
25mg98%$778.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3R,4R,E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid
IUPAC Name(2S,3R,4R,E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid
MDL No.MFCD01632772
Molecular FormulaC21H39NO6
Molecular Weight401.54
SMILESCCCCCCC(CCCCCC/C=C/C[C@@H](O)[C@H](O)[C@](CO)(N)C(O)=O)=O
InChI KeyZZIKIHCNFWXKDY-GNTQXERDSA-N
Synonym6-EICOSENOIC ACID, 2-AMINO-3,4-DIHYDROXY-2-(HYDROXYMETHYL)-14-OXO-, (2S,3R,4R,6E) | SR-05000002333-3 | UNII-YRM4E8R9ST | VRP | YRM4E8R9ST | F85634 | NCGC00163597-04 | (2S,3R,4R,E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid | (E,2S,3R,
CAS No.35891-70-4
PubChem CID6438394

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301
Precautionary Statement(s)
P301+P310

Synthetic Route by SureRoute

1. ACTJKO184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTJKO184 route product structure diagram
    ACTJKO18435891-70-4
Inquiry

2. ACTJKO184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTJKO184 route product structure diagram
    ACTJKO18435891-70-4
Inquiry

Comments (0)